JP2021134168A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021134168A5 JP2021134168A5 JP2020031364A JP2020031364A JP2021134168A5 JP 2021134168 A5 JP2021134168 A5 JP 2021134168A5 JP 2020031364 A JP2020031364 A JP 2020031364A JP 2020031364 A JP2020031364 A JP 2020031364A JP 2021134168 A5 JP2021134168 A5 JP 2021134168A5
- Authority
- JP
- Japan
- Prior art keywords
- levetiracetam
- tablet
- water
- soluble
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- HPHUVLMMVZITSG-ZCFIWIBFSA-N levetiracetam Chemical compound CC[C@H](C(N)=O)N1CCCC1=O HPHUVLMMVZITSG-ZCFIWIBFSA-N 0.000 claims 9
- 229960004002 levetiracetam Drugs 0.000 claims 9
- 238000004519 manufacturing process Methods 0.000 claims 6
- 239000000654 additive Substances 0.000 claims 5
- 239000002245 particle Substances 0.000 claims 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 4
- 230000000996 additive effect Effects 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 2
- 239000007888 film coating Substances 0.000 claims 2
- 238000009501 film coating Methods 0.000 claims 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 2
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020031364A JP7300725B2 (ja) | 2020-02-27 | 2020-02-27 | 固形製剤及びその製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020031364A JP7300725B2 (ja) | 2020-02-27 | 2020-02-27 | 固形製剤及びその製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021134168A JP2021134168A (ja) | 2021-09-13 |
| JP2021134168A5 true JP2021134168A5 (https=) | 2022-09-16 |
| JP7300725B2 JP7300725B2 (ja) | 2023-06-30 |
Family
ID=77660260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020031364A Active JP7300725B2 (ja) | 2020-02-27 | 2020-02-27 | 固形製剤及びその製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7300725B2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114917195B (zh) * | 2022-06-13 | 2024-06-11 | 河北戴桥医药科技有限公司 | 一种吡拉西坦片剂及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000053711A (ja) | 1998-08-11 | 2000-02-22 | Clariant Polymer Kk | 再分散性エマルジョン粉末及びその製造方法 |
| CN101111245A (zh) | 2005-01-27 | 2008-01-23 | 阿雷姆贝克有限公司 | 左乙拉西坦延长释放制剂 |
| JP4963877B2 (ja) | 2005-06-10 | 2012-06-27 | 日本合成化学工業株式会社 | 合成樹脂エマルジョン組成物の再分散性粉末 |
| EP2179725A1 (en) | 2008-10-23 | 2010-04-28 | LEK Pharmaceuticals D.D. | Pharmaceutical composition comprising levetiracetam |
| JP6630229B2 (ja) | 2016-05-17 | 2020-01-15 | エルメッド株式会社 | レベチラセタム含有医薬組成物及びその製造方法 |
| JP7023054B2 (ja) | 2017-04-05 | 2022-02-21 | 東和薬品株式会社 | レベチラセタム含有医薬組成物及びその製造方法 |
| US20200113839A1 (en) | 2017-05-02 | 2020-04-16 | Lubrizol Advanced Materials, Inc. | Extended Release Highly Loaded Drug Compositions |
-
2020
- 2020-02-27 JP JP2020031364A patent/JP7300725B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3263110T3 (fi) | Tabletti, joka käsittää metoksiureajohdannaista ja mannitolipartikkeleita | |
| JP2009540111A5 (https=) | ||
| JP2005519858A5 (ja) | 制御放出医薬製剤の製造方法及び制御放出医薬製剤 | |
| SI2821067T1 (en) | Quick spray formulation of cinacalcet | |
| US12533320B2 (en) | Oral sustained-release composition for insoluble drug, and preparation method thereof | |
| CN105658208B (zh) | 含甘磷酸胆碱的薄膜包衣片剂及其制备方法 | |
| JPWO2009028583A1 (ja) | コーティング製剤の製造方法 | |
| JP2025085845A (ja) | ブルトン型チロシンキナーゼ阻害剤を含む経口固体錠剤及びその調製方法 | |
| JP2012509329A5 (https=) | ||
| JP2019506420A5 (https=) | ||
| JP2021134168A5 (https=) | ||
| JP2020082072A5 (https=) | ||
| JP2004517064A (ja) | 活性成分をベースとする微小顆粒およびその製造方法 | |
| JP2009519849A5 (https=) | ||
| JP2022529672A5 (https=) | ||
| JP2018016719A5 (https=) | ||
| JP2017222645A (ja) | 腸溶性被覆顆粒の耐酸性が改善された圧縮成形錠剤 | |
| JP2018177657A (ja) | レベチラセタム含有医薬組成物及びその製造方法 | |
| JP2011251959A5 (https=) | ||
| JPWO2023027056A5 (https=) | ||
| WO2021172395A1 (ja) | 被覆原薬粒子 | |
| CN111902161A (zh) | 含达比加群酯的药物组合物及其制备方法 | |
| WO2009087657A2 (en) | Stable pharmaceutical composition of duloxetine and process for its preparation | |
| CN111297810A (zh) | 甲苯磺酸索拉非尼药物组合物及其制备方法 | |
| JP2020519669A5 (https=) |